Hepatitis B virus X protein stimulates the Hedgehog–Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells
“…Previous evidence has demonstrated that the Hh signaling plays an important role in multiple tumor types. This signaling pathway is involved in and participates development, invasion and metastasis of HCC [34][35][36][37][38][39][40] . In this study, we further detected expression of Shh and Gli1 in metastasis and non-metastasis HCC liver tissues, simultaneously we used KAAD-cyc, a specific inhibitor of Hh pathway and Shh, a ligand of the Hh pathway in invasion and metastasis assays of human HCC cell line, and we confirmed the results.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have revealed that the Hh signaling pathway is abnormally activated in human HCC [34][35][36] , and this pathway is thought to participate in the development of HCC [37][38][39] . Moreover, activation of the Hh pathway is correlated closely to invasion and metastasis of HCC [36,40] .…”
Aim: To investigate the role of Hedgehog (Hh) signaling pathway in the invasion and metastasis of human hepatocellular carcinoma (HCC). Methods: Eighty six HCC tissues samples and HCC cell line Bel-7402 were examined. The protein expression of sonic hedgehog (Shh), nuclear glioma-associated oncogene-1 (Gli1), MMP-9 and p-ERK1/2 in HCC was analyzed using immunohistochemistry and Western blot analysis. Boyden chamber assay and wound-healing assay were used to quantify the invasion and metastasis of Bel-7402 cells. Results: In 86 HCC tissue samples, the positive ratio of Shh and nucleus Gli1 was 67.44% (58/86) and 60.47% (52/86), respectively; the expression of nucleus Gli1 was correlated with the tumor pathological grade (P=0.034), and with the ability of the tumor to invade and metastasize (P=0.001); the expression of nucleus Gli1 was also correlated with p-ERK1/2 (P=0.031) and with MMP-9 (P=0.034). Neither Shh, nor nucleus Gli1 was observed in normal liver tissue. KAAD-cyclopamine (KAAD-cyc), a specific inhibitor of the Hh pathway, at the concentrations of 1 and 4 μmol/L inhibited the invasion and migration of Bel-7402 cells and decreased the expression of Gli1 in nucleus and MMP-9, p-ERK1/2 proteins in Bel-7402 cells. On the other hand, Shh, a ligand of the Hh pathway, at the concentration of 0.5 μg/mL produced opposite effects. The MAPK pathway inhibitors U0126 and PD98059 at the concentrations of 5 and 10 μmol/L inhibited invasion and metastasis of Bel-7402 cells induced by Shh, and decreased the expression of p-ERK1/2 and MMP-9. However, U0126 and PD98059 had no effect on the expression of Gli1. Conclusion: Hh signaling pathway mediates invasion and metastasis of human HCC by up-regulating the protein expression of MMP-9 via ERK pathway.
“…Previous evidence has demonstrated that the Hh signaling plays an important role in multiple tumor types. This signaling pathway is involved in and participates development, invasion and metastasis of HCC [34][35][36][37][38][39][40] . In this study, we further detected expression of Shh and Gli1 in metastasis and non-metastasis HCC liver tissues, simultaneously we used KAAD-cyc, a specific inhibitor of Hh pathway and Shh, a ligand of the Hh pathway in invasion and metastasis assays of human HCC cell line, and we confirmed the results.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have revealed that the Hh signaling pathway is abnormally activated in human HCC [34][35][36] , and this pathway is thought to participate in the development of HCC [37][38][39] . Moreover, activation of the Hh pathway is correlated closely to invasion and metastasis of HCC [36,40] .…”
Aim: To investigate the role of Hedgehog (Hh) signaling pathway in the invasion and metastasis of human hepatocellular carcinoma (HCC). Methods: Eighty six HCC tissues samples and HCC cell line Bel-7402 were examined. The protein expression of sonic hedgehog (Shh), nuclear glioma-associated oncogene-1 (Gli1), MMP-9 and p-ERK1/2 in HCC was analyzed using immunohistochemistry and Western blot analysis. Boyden chamber assay and wound-healing assay were used to quantify the invasion and metastasis of Bel-7402 cells. Results: In 86 HCC tissue samples, the positive ratio of Shh and nucleus Gli1 was 67.44% (58/86) and 60.47% (52/86), respectively; the expression of nucleus Gli1 was correlated with the tumor pathological grade (P=0.034), and with the ability of the tumor to invade and metastasize (P=0.001); the expression of nucleus Gli1 was also correlated with p-ERK1/2 (P=0.031) and with MMP-9 (P=0.034). Neither Shh, nor nucleus Gli1 was observed in normal liver tissue. KAAD-cyclopamine (KAAD-cyc), a specific inhibitor of the Hh pathway, at the concentrations of 1 and 4 μmol/L inhibited the invasion and migration of Bel-7402 cells and decreased the expression of Gli1 in nucleus and MMP-9, p-ERK1/2 proteins in Bel-7402 cells. On the other hand, Shh, a ligand of the Hh pathway, at the concentration of 0.5 μg/mL produced opposite effects. The MAPK pathway inhibitors U0126 and PD98059 at the concentrations of 5 and 10 μmol/L inhibited invasion and metastasis of Bel-7402 cells induced by Shh, and decreased the expression of p-ERK1/2 and MMP-9. However, U0126 and PD98059 had no effect on the expression of Gli1. Conclusion: Hh signaling pathway mediates invasion and metastasis of human HCC by up-regulating the protein expression of MMP-9 via ERK pathway.
“…In chronic liver diseases, induced by HBV and HCV, virus-related proteins interact with k-Ras, Hedgehog-, Notch-, TGF-band Wnt/b catenin signaling cascades and alter their functions, promoting liver carcinogenesis. Perturbation of these intracellular paths by both viruses has been reported, in vitro, in hepatoma and cancer cell lines [156][157][158][159][160][161]165,166,172,173,[176][177][178][179][180]. Therefore, it may be hypothised that the same viral proteins, which are involved in HCC development, might have analogous activities also in pancreatic cells and favour their malignant transformation.…”
Section: Activity Of Cellular Signalling Cascadesmentioning
confidence: 97%
“…-Increased transcription of HypoxiaInducible Factor-1a (HIF-1a) and of its target genes (VEGF and TGF-b), via HCVcore protein [189] Cellular pathways K-Ras-pathway -Interaction with other intracellular signalingcascades, such as Notch pathway; -modulation of different cellular properties (proliferation, differentiation, adhesion and apoptosis) [128][129][130] Increased RAS activity levels beyond a critical threshold caused by: -inflammatory stimuli or spontaneous events; -deletion or mutation of tumor suppressors, including p53, p16 and p19, with deregulation of oncogenecontrolled senescence [130][131][132][133][134] Increased activity, induced by HBx protein, with deregulation of cell-cycle checkpoint controls [160] Increased activity, induced by HCV core and NS5A proteins, with deregulation of cell-cycle checkpoint controls [159] Hedgehog-pathway -Interaction with Wnt/b catenin-, Rasand Transforming growth factor-b pathways; -modulation of different cellular properties (proliferation, differentiation, adhesion and apoptosis) [164][165][166].…”
“…Given that hedgehog signaling is www.intechopen.com also known to promote tissue remodeling in the liver (Omenetti & Diehl, 2008), it is possible that this may contribute to the progression and formation of cirrhotic nodules in the liver of chronically infected patients. Preliminary data also suggests that HBx activates hedgehog signaling in liver cancer cells (Kim et al, 2011), although the role of this activation in hepatocarcinogenesis remains to be studied. Further, it is not clear whether the upregulation of hedgehog ligands is activated by HBx, and whether this in some way contributes to fibrogenesis.…”
Section: Does Hbx Activate Stellate Cells?mentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.